UK's Hikma Pharma holds annual outlook, prepares for US generic drug tariffs British generic drugmaker Hikma Pharmaceuticals posted a rise in first-half core operating profit and maintained its annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results